Assessing heart function in children with single-ventricle congenital heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate a new 3D echocardiographic technique for measuring cardiac size and function in children and young adults with functional single ventricles. Current echocardiographic methods are limited by geometric assumptions and challenges in visualizing malformed hearts. The study will compare this new technique to the gold standard of cardiac MRI to determine its accuracy and effectiveness. Participants will include those who have undergone or are scheduled for a transthoracic echocardiogram or cardiac MRI.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI.

Exclusion Criteria:

* Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.

Where it's running

• Duke University
  Durham, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Piers Barker, MD — Duke University
• Study coordinator: Joan Wilson
• Email: joan.wilson@duke.edu
• Phone: 999999999

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating the effectiveness of SGLT2 inhibitors in adults with congenital heart disease

  This study is trying to see if a new type of diabetes medication can help adults with congenital heart disease feel better and manage their heart failure symptoms.

  Recruiting at 11 sites Leiden University Medical Center · Baltimore, Maryland and 10 other locations · NCT06932081

• Improving fitness for adolescents with the Fontan circulation

  This study will test whether a home-based digital exercise program helps 10–17-year-olds with the Fontan circulation become more active and improve fitness compared with enhanced usual care.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT06918795

• Integrated prenatal and postnatal treatment for newborns with critical congenital heart disease

  This study is testing a new approach that combines care before and after birth for newborns with serious heart defects to see if it can improve their treatment and recovery.

  Recruiting Beijing Anzhen Hospital · Beijing · NCT06768008

• Profiling micro RNA in newborns with congenital heart disease

  This study is trying to understand how certain molecules in the blood of newborns with severe congenital heart disease affect their risk of blood clots during surgery.

  Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06434207

• Long-term safety follow-up after autologous cardiac stem cells in kids with single ventricle heart disease

  This study checks whether autologous cardiac stem cells (JRM-001) remain safe for up to a year in children who already received them after heart reconstructive surgery.

  Recruiting Metcela Inc. · Okayama, Okayama-ken · NCT07884318

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.